+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


MICARDIS HCT Drug Profile, 2019

  • ID: 4727046
  • Report
  • October 2020
  • Region: Global
  • 66 pages
  • thinkBiotech LLC
MICARDIS HCT Drug Profile, 2019 is part of a deep library of business intelligence on biopharmaceutical drugs.

The report focuses on MICARDIS HCT and covers the following critical aspects of this drug:
  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • European supplementatry protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
About the Researcher

The researcher is a provider of global business intelligence on biologic and small-molecule drugs, dedicated to helping clients make better decisions. Critical information on global drug patents is incorporated with litigation intelligence, drug prices, and historic sales figures to help users discover commercial opportunities and forecast future revenue events. Since 2005 the researcher has served hundreds of large and small companies in more than 65 countries.
Note: Product cover images may vary from those shown
  • Profile for MICARDIS HCT
  • US Patents
  • Expired US Patents
  • Paragraph IV Patent Challenges
  • International (ex US) Patents
  • Supplementary Protection Certificates
  • Clinical Trials
  • Drug Prices - Best Wholesale Price
  • Annual Sales Revenues
  • Finished Product Suppliers
Note: Product cover images may vary from those shown


  • Boehringer Ingelheim Pharmaceuticals Inc.
  • West-Ward Pharmaceuticals Corp.
Note: Product cover images may vary from those shown